Boule Diagnostics AB (publ) (STO: BOUL)
Sweden flag Sweden · Delayed Price · Currency is SEK
6.78
+0.04 (0.59%)
Nov 19, 2024, 4:29 PM CET

Boule Diagnostics AB Company Description

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East.

The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand.

It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics companies.

Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden.

Boule Diagnostics AB (publ)
Country Sweden
Founded 1956
Industry Medical Devices
Sector Healthcare
Employees 228
CEO Torben Nielsen

Contact Details

Address:
Domnarvsgatan 4
Spånga, 163 53
Sweden
Phone 46 87 44 77 00
Website boule.com

Stock Details

Ticker Symbol BOUL
Exchange Nasdaq Stockholm
Fiscal Year January - December
Reporting Currency SEK
ISIN Number SE0011231158
SIC Code 2835

Key Executives

Name Position
Torben Nielsen Chief Executive Officer and Group President
Holger Lembrer M.Sc. Chief Financial Officer
Eduardo Pagani Chief Operating Officer
Jorgen Jehander Head of Development Department and Interim Chief Technology Officer
Simonetta Tumbiolo Senior Vice President of Marketing
Aishat Bislieva Senior Vice President of People and Culture
David Metrena Senior Vice President of Commercial Operations of US